{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:47Z","timestamp":1787181887433,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013306","name":"National Institute of Science Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001502","name":"Government of India Department of Atomic Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119789","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:49:41Z","timestamp":1784666981000},"page":"119789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fluorinated isoindolinone\u2013amino acid hybrids possessing antiproliferative and antitumor activity in vitro and in vivo"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6177-9484","authenticated-orcid":false,"given":"Soma","family":"Mandal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4514-8194","authenticated-orcid":false,"given":"Rajat","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9263-0134","authenticated-orcid":false,"given":"A.A.I. Parvaj","family":"Laskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3699-7490","authenticated-orcid":false,"given":"V. Badireenath","family":"Konkimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119789_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021"},{"key":"10.1016\/j.biopha.2026.119789_bib2","article-title":"Personalizing therapies over the course of hormone receptor-positive\/HER2-negative metastatic breast cancer","volume":"76","author":"Singareeka Raghavendra","year":"2026","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.biopha.2026.119789_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s12276-025-01395-3","article-title":"Targeting CDK4\/6 in breast cancer","volume":"57","author":"Shanabag","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119789_bib4","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","article-title":"Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer","volume":"375","author":"Hortobagyi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119789_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41388-025-03378-0","article-title":"Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment","volume":"44","author":"Guo","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119789_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drudis.2019.12.001","article-title":"Targeting CDK2 in cancer: challenges and opportunities for therapy","volume":"25","author":"Tadesse","year":"2020","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.biopha.2026.119789_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119789_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105427","article-title":"The evolving landscape of CDK2 inhibition in cancer: Therapeutic potential, clinical progress, and future directions","volume":"226","author":"Lenjisa","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2026.119789_bib9","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/0008-5472.CAN-15-0728","article-title":"Early adaptation and acquired resistance to CDK4\/6 inhibition in estrogen receptor-positive breast cancer","volume":"76","author":"Herrera-Abreu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119789_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/med.21769","article-title":"How selective are clinical CDK4\/6 inhibitors?","volume":"41","author":"Hendrychov\u00e1","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2026.119789_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104324","article-title":"Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions","volume":"196","author":"Gerosa","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biopha.2026.119789_bib12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd4366","article-title":"Phenotypic screening in cancer drug discovery-past, present and future","volume":"13","author":"Moffat","year":"2014","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119789_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.tips.2024.06.001","article-title":"Innovating cancer drug discovery with refined phenotypic screens","volume":"45","author":"Wang","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2026.119789_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70261","article-title":"Synthesis of Novel Isoindolinones: Carbonic Anhydrase Inhibition Profiles, Antioxidant Potential, Antimicrobial Effect, Cytotoxicity and Anticancer Activity","volume":"39","author":"Yaz\u0131c\u0131o\u011flu","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.biopha.2026.119789_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500420","article-title":"Progress In the Chemistry and Pharmacology of Isoindolin-1-One Scaffolds","volume":"20","author":"Madaan","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2026.119789_bib16","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1021\/acs.jmedchem.4c02206","article-title":"Design, Synthesis, Evaluation, and SAR of 5-Phenylisoindoline Derivatives, a Potent Class of Small-Molecule Inhibitors Targeting the Programmed Cell Death-1\/Programmed Cell Death-Ligand 1 (PD-1\/PD-L1) Interaction","volume":"68","author":"Lu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/org6010003","article-title":"Synthesis and Pharmacology of Clinical Drugs Containing Isoindoline Heterocycle Core","volume":"6","author":"Jha","year":"2025","journal-title":"Organics"},{"key":"10.1016\/j.biopha.2026.119789_bib18","doi-asserted-by":"crossref","first-page":"12512","DOI":"10.1021\/acsomega.3c00560","article-title":"Evaluation of In Vivo Biological Activity Profiles of Isoindole-1,3-dione Derivatives: Cytotoxicity, Toxicology, and Histopathology Studies","volume":"8","author":"K\u00f6se","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2026.119789_bib19","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1021\/acs.jmedchem.6b00777","article-title":"Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma","volume":"59","author":"Span\u00f2","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.pmch.2014.11.001","article-title":"Fluorine in medicinal chemistry","volume":"54","author":"Swallow","year":"2015","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib21","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of Fluorine in Medicinal Chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14756360701425014","article-title":"The role of fluorine in medicinal chemistry","volume":"22","author":"Shah","year":"2007","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib23","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1186\/s40001-025-03538-8","article-title":"The efficacy and safety of datopotamab deruxtecan (Dato-DXd) in advanced solid tumors: a systematic review and meta-analysis","volume":"30","author":"Huang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.biopha.2026.119789_bib25","doi-asserted-by":"crossref","first-page":"e1193","DOI":"10.1016\/j.jpainsymman.2026.04.539","article-title":"Suzetrigine: successful treatment of a young adult with breast cancer-associated neuropathic and nociceptive pain","volume":"71","author":"Schaffer","year":"2026","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.biopha.2026.119789_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","article-title":"Hybrid molecules: The privileged scaffolds for various pharmaceuticals","volume":"124","author":"Shaveta","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117963","article-title":"Amino acid\u2013modified chalcone derivatives with in vitro and in vivo efficacy against colon cancer","volume":"297","author":"El-Haggar","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1039\/D5MD00760G","article-title":"Stereoselective design of amino acid bioconjugates: targeting strategies and physicochemical optimization","volume":"17","author":"Mandal","year":"2026","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/molecules27217631","article-title":"Amino-Acid-Conjugated Natural Compounds: Aims, Designs and Results","volume":"27","author":"Arifian","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119789_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118336","article-title":"Synthesis of \u03b2-boswellic acid-amino acid conjugates for targeting KRASG13D mutant colon cancer","volume":"302","author":"Qayum","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/acs.oprd.8b00276","article-title":"Development of Kilogram-Scale Synthesis of EGFR Inhibitor EAI045","volume":"23","author":"Hao","year":"2019","journal-title":"Org. Process. Res. Dev."},{"key":"10.1016\/j.biopha.2026.119789_bib32","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.3390\/molecules200610487","article-title":"Efficient esterification of oxidized l-glutathione and other small peptides","volume":"20","author":"Vogel","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119789_bib33","article-title":"Hydrophobic and Polarized Aromatic Residues Promote Internalization of Arg-Rich Cell-Penetrating Peptides through Ionpair-\u03c0 Interactions","volume":"31","author":"Khemaissa","year":"2025","journal-title":"Chemistry"},{"key":"10.1016\/j.biopha.2026.119789_bib34","article-title":"Recent Advances in Bioconjugation of Aromatic Amino Acid Residues by a Reactivity-Guided Approach","author":"Santos","year":"2025","journal-title":"Chem. Rec."},{"key":"10.1016\/j.biopha.2026.119789_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119789_bib36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.biopha.2026.119789_bib37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tig.2024.02.006","article-title":"PCNA cycling dynamics during DNA replication and repair in mammals","volume":"40","author":"Kang","year":"2024","journal-title":"Trends Genet."},{"key":"10.1016\/j.biopha.2026.119789_bib38","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1039\/D4TB01236D","article-title":"Engineering of redox-triggered polymeric lipid hybrid nanocarriers for selective drug delivery to cancer cells","volume":"13","author":"Lokesh","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2026.119789_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106854","article-title":"Dual drug nanoparticle synergistically induced apoptosis, suppressed inflammation, and protected autophagic response in rheumatoid arthritis fibroblast-like synoviocytes","volume":"267","author":"Haloi","year":"2024","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2026.119789_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119789_bib41","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1093\/nar\/gkab835","article-title":"Erratum: The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets (Nucleic Acids Research (2021) 49 (D605\u2013D612) DOI: 10.1093\/nar\/gkaa1074)","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119789_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: Identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.biopha.2026.119789_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1432-1033.1994.00771.x","article-title":"Inhibition of cyclin-dependent kinases by purine analogues","volume":"224","author":"Vesel\u00fd","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biopha.2026.119789_bib44","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.biopha.2026.119789_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2026.119789_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112467","article-title":"Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moiety","volume":"200","author":"Soliman","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:47:26Z","timestamp":1787179646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"alternative-id":["S0753332226008255"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119789","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorinated isoindolinone\u2013amino acid hybrids possessing antiproliferative and antitumor activity in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119789"}}